Daiwa Securities Group’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2K | Hold |
239
| – | – | ﹤0.01% | 1224 |
|
|
2025
Q1 | $2K | Hold |
239
| – | – | ﹤0.01% | 1195 |
|
|
2024
Q4 | $1K | Hold |
239
| – | – | ﹤0.01% | 1266 |
|
|
2024
Q3 | $2K | Hold |
239
| – | – | ﹤0.01% | 1229 |
|
|
2024
Q2 | $3K | Hold |
239
| – | – | ﹤0.01% | 1226 |
|
|
2024
Q1 | $4K | Hold |
239
| – | – | ﹤0.01% | 1218 |
|
|
2023
Q4 | $5K | Hold |
239
| – | – | ﹤0.01% | 1198 |
|
|
2023
Q3 | $5K | Hold |
239
| – | – | ﹤0.01% | 1158 |
|
|
2023
Q2 | $11K | Hold |
239
| – | – | ﹤0.01% | 1129 |
|
|
2023
Q1 | $10K | Hold |
239
| – | – | ﹤0.01% | 1103 |
|
|
2022
Q4 | $9K | Buy |
239
+19
| +9% | +$715 | ﹤0.01% | 1114 |
|
|
2022
Q3 | $9K | Hold |
220
| – | – | ﹤0.01% | 1127 |
|
|
2022
Q2 | $7K | Buy |
220
+48
| +28% | +$1.53K | ﹤0.01% | 1143 |
|
|
2022
Q1 | $6K | Hold |
172
| – | – | ﹤0.01% | 1158 |
|
|
2021
Q4 | $7K | Sell |
172
-29
| -14% | -$1.18K | ﹤0.01% | 1165 |
|
|
2021
Q3 | $9K | Buy |
201
+85
| +73% | +$3.81K | ﹤0.01% | 1149 |
|
|
2021
Q2 | $7K | Hold |
116
| – | – | ﹤0.01% | 1056 |
|
|
2021
Q1 | $9K | Buy |
116
+18
| +18% | +$1.4K | ﹤0.01% | 1047 |
|
|
2020
Q4 | $8K | Sell |
98
-194
| -66% | -$15.8K | ﹤0.01% | 1028 |
|
|
2020
Q3 | $18K | Hold |
292
| – | – | ﹤0.01% | 993 |
|
|
2020
Q2 | $8K | Hold |
292
| – | – | ﹤0.01% | 1067 |
|
|
2020
Q1 | $8K | Sell |
292
-3,431
| -92% | -$94K | ﹤0.01% | 1064 |
|
|
2019
Q4 | $269K | Buy |
3,723
+318
| +9% | +$23K | ﹤0.01% | 859 |
|
|
2019
Q3 | $478K | Sell |
3,405
-320
| -9% | -$44.9K | ﹤0.01% | 693 |
|
|
2019
Q2 | $682K | Sell |
3,725
-566
| -13% | -$104K | 0.01% | 569 |
|
|
2019
Q1 | $683K | Buy |
4,291
+3,981
| +1,284% | +$634K | 0.01% | 563 |
|
|
2018
Q4 | $30K | Buy |
310
+80
| +35% | +$7.74K | ﹤0.01% | 942 |
|
|
2018
Q3 | $32K | Hold |
230
| – | – | ﹤0.01% | 970 |
|
|
2018
Q2 | $36K | Hold |
230
| – | – | ﹤0.01% | 978 |
|
|
2018
Q1 | $37K | Buy |
+230
| New | +$37K | ﹤0.01% | 959 |
|